In order to validate the prognostic value of MSH6 expression on high-grade astrocytomas survival, we evaluated MSH6 protein expression in an independent cohort of 71 high-grade astrocytomas. This evidence concerns the gene MSH6 and astrocytoma (excluding glioblastoma).